Wellington Management Group LLP 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 09:29 am Sale |
2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Wellington Management Group LLP | 1,104,531 1.540% |
-2,293,341 (-67.49%) |
Filing |
| 2021-02-04 11:42 am Sale |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Wellington Management Group LLP | 3,397,872 5.110% |
-345,828 (-9.24%) |
Filing |
| 2020-08-10 09:43 am Sale |
2020-07-31 | 13G | Revance Therapeutics, Inc. RVNC |
Wellington Management Group LLP | 3,743,700 5.680% |
-2,044,345 (-35.32%) |
Filing |